Vasina V - Search Results

1

Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats.

Vasina V, Broccoli M, Ursino MG, Bellot SF, Soleti A, Paolini M, De Ponti F. Vasina V, et al. Eur J Pharmacol. 2009 Jul 1;614(1-3):137-45. doi: 10.1016/j.ejphar.2009.04.021. Epub 2009 Apr 19. Eur J Pharmacol. 2009. PMID: 19383495

2

Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.

Ursino MG, Vasina V, De Ponti F. Ursino MG, et al. Among authors: vasina v. Eur J Pharmacol. 2009 Jan 28;603(1-3):133-7. doi: 10.1016/j.ejphar.2008.11.064. Epub 2008 Dec 14. Eur J Pharmacol. 2009. PMID: 19103194

3

Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats.

Vasina V, Broccoli M, Ursino MG, Canistro D, Valgimigli L, Soleti A, Paolini M, De Ponti F. Vasina V, et al. World J Gastroenterol. 2010 Aug 7;16(29):3642-50. doi: 10.3748/wjg.v16.i29.3642. World J Gastroenterol. 2010. PMID: 20677336 Free PMC article.

4

Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.

Raschi E, Vasina V, Ursino MG, Boriani G, Martoni A, De Ponti F. Raschi E, et al. Among authors: vasina v. Pharmacol Ther. 2010 Feb;125(2):196-218. doi: 10.1016/j.pharmthera.2009.10.002. Epub 2009 Oct 27. Pharmacol Ther. 2010. PMID: 19874849 Review.

5

Animal models of chemically induced intestinal inflammation: predictivity and ethical issues.

Dothel G, Vasina V, Barbara G, De Ponti F. Dothel G, et al. Among authors: vasina v. Pharmacol Ther. 2013 Jul;139(1):71-86. doi: 10.1016/j.pharmthera.2013.04.005. Epub 2013 Apr 4. Pharmacol Ther. 2013. PMID: 23563278 Review.

6

The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats.

Vasina V, Abu-Gharbieh E, Barbara G, de Giorgio R, Colucci R, Blandizzi C, Bernardini N, Croci T, Del Tacca M, de Ponti F. Vasina V, et al. Neurogastroenterol Motil. 2008 Sep;20(9):1030-41. doi: 10.1111/j.1365-2982.2008.01138.x. Epub 2008 May 15. Neurogastroenterol Motil. 2008. PMID: 18492028

7

The beta3-adrenoceptor as a therapeutic target: current perspectives.

Ursino MG, Vasina V, Raschi E, Crema F, De Ponti F. Ursino MG, et al. Among authors: vasina v. Pharmacol Res. 2009 Apr;59(4):221-34. doi: 10.1016/j.phrs.2009.01.002. Epub 2009 Jan 24. Pharmacol Res. 2009. PMID: 19429463 Review.

8

Antibacterial macrolides: a drug class with a complex pharmacological profile.

Abu-Gharbieh E, Vasina V, Poluzzi E, De Ponti F. Abu-Gharbieh E, et al. Among authors: vasina v. Pharmacol Res. 2004 Sep;50(3):211-22. doi: 10.1016/j.phrs.2004.01.008. Pharmacol Res. 2004. PMID: 15225662 Review.

9

Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.

Vasina V, Giannone F, Domenicali M, Latorre R, Berzigotti A, Caraceni P, Zoli M, De Ponti F, Bernardi M. Vasina V, et al. Br J Pharmacol. 2012 Nov;167(5):1137-47. doi: 10.1111/j.1476-5381.2012.02074.x. Br J Pharmacol. 2012. PMID: 22708587 Free PMC article.

10

The hERG K+ channel: target and antitarget strategies in drug development.

Raschi E, Vasina V, Poluzzi E, De Ponti F. Raschi E, et al. Among authors: vasina v. Pharmacol Res. 2008 Mar;57(3):181-95. doi: 10.1016/j.phrs.2008.01.009. Epub 2008 Feb 2. Pharmacol Res. 2008. PMID: 18329284 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters